Schisandrin B for Treatment of Male Infertility

Dixin Zou,Xue-Dan Meng,Yuan Xie,Rui Li,Jingli Duan,Yixuan Liu,Ya-Fei Du,Jiacheng Xu,Eric Luo,Zhan Zhang,Shaoping Ma,Weipeng Yang,Rui‐Chao Lin,Wan-Liang Lü
DOI: https://doi.org/10.2139/ssrn.3566100
2020-01-01
Abstract:The decline of male fertility and its consequences on human populations are important public-health issues. However, there are limited choices for treatment of male infertility. In an attempt to identify a compound that could promote male fertility, we identified and characterized a library of small molecules from an ancient formulation Wuzi Yanzong-Pill, which was used as a folk medicine since the Tang dynasty of China. We found that SB enabled evident repairs in oligoasthenospermia-associated testicular tissue abnormality and in spermatogenesis disruption, resulting in significant improvements of sperm count, mobility, and reproductive ability in oligoasthenospermia mice. Furthermore, SB could alter substantial testicular genes (2033), among which, upregulation of Fst while downregulation of Inhba involved in reproductive signaling pathway could explain its role in enhancing spermatogenesis. The encouraging preclinical data with pharmacokinetics warranted a rapid development of this new class of therapeutic agent. Our finding provides a strong potent drug for treatment of male infertility.Funding Statement: This work was supported by Beijing Natural Science Foundation (7181004), National Chinese Medicine Standardized Project of China (ZYBZH-C-BJ-03) and in part by National Natural Science Foundation of China (81673367, 81874303, 81760837).Declaration of Interests: The authors declare no competing interests in relation to publication of this study.Ethics Approval Statement: All procedures involving the care and handing of animals were carried out with approval of the Authorities for Laboratory Animal Care of Peking University (Beijing, China; LA2018330).
What problem does this paper attempt to address?